This paper investigates consequences of vaccine implementation strategies for infectious diseases by a mathematical model. For an infectious disease, the degree of infection may vary widely among the individuals. Reports show that individuals belonging to certain groups possess considerably higher risk to infection. Incorporating this phenomenon into vaccination strategies, the host is categorized into different groups to measure the outcome of the vaccination. A mathematical model is proposed and analysed to evaluate this measure. Our results suggest that vaccinating a group with certain priority may lead to elimination of the disease effectively. The strategy is cost-effective as well.
Introduction
Vaccine has had a successful history since Edward Jenner's discovery of smallpox vaccine in the eighteenth century [18] . His innovation is widely regarded as the foundation of immunology. With the rapid pace of vaccine development medical science has saved millions of lives from dreadful diseases during the last two centuries. Small pox eradication can be worth mentioning as a successful example in this regard [1, 30] . Vaccines also contribute significantly to reducing infections of influenza, polio and many other life threatening diseases [21, 29] . In today's life, it is unusual and rare for a child not to receive any vaccines.
A vaccine typically contains an agent that resembles a disease-causing microorganism which stimulates the immune system of host and builds up antibody against the virus to recognize the agent as a foreigner. Thus, whenever such a microorganism is encountered within a host, the immune system destroys it. This kind of phenomenon is known as immunity. Thus, as long as a vaccine for a disease is available, it is an ideal means of protecting a healthy population from the disease.
An individual may receive vaccines available for a disease that is prevalent in his region. Vaccines of some diseases are already developed and one can take the vaccine if the particular *Corresponding author. Email: xzou@uwo.ca Author Email: srahma33@uwo.ca disease is threat for him. For example, an individual can take a polio vaccine or a seasonal flu vaccine which are already available. However, when a new infectious disease emerges but no vaccine is available for it, the disease may cause significant infections and deaths. It takes some time to devise an effective vaccine if successful.
Once a vaccine is available, a natural and immediate question arises: how to allocate and implement this vaccine [31, 34] . Certainly we cannot vaccinate all the individuals to eradicate the disease overnight. In addition to social and ethical issues, high cost may prevent universal distribution of vaccines [25] . Certain group of individuals may pose higher risk to the infections than the others. In influenza, for example, school-going children can be infected more easily and can spread the disease more rapidly than other individuals [10, 16, 20, 21] . Thus to control infections by using vaccines, a proper distribution and implementation strategy is very important. Priority may need to be given to certain group(s) or individuals by the health professionals. Current practice of vaccine allocation highlights the importance of identifying the groups which are at highest risk for adverse health [24] . Effectiveness of such a vaccine allocation strategy can be determined through analysis of a mathematical model. In this paper, we aim to shed some light on this critical issue and hope to provide a useful guideline to the policy-maker.
To properly implement the vaccination campaign, a plausible and intellectual idea may be to immunize individuals belonging to certain groups or locations that are most vulnerable to infections. The transmission rates in these groups are much higher than those in the other groups in which individuals are less susceptible or they are located in a comparatively safe area. The individuals in the target groups may need more protections so that the overall infections can be controlled effectively. In this paper, we formulate and analyse a mathematical model that incorporates prioritized group-vaccination strategy.
The rest of this paper is organized as follows. In Section 2, we formulate a two-group model based on the individual's risk status. The basic reproduction number of the model, the equilibria of the model and their stability, as well as the disease persistence are discussed in Section 3. Finally, in Section 4, we discuss the policy of vaccine allocation and distribution based on the model outcomes and offer some concluding remarks.
Mathematical model
As indicated in the previous section, we divide the total population into two groups: the risky (r) group in which the infection rates are much higher within the group; and the critical (c) group in which the individuals are conscious in their social behaviour, or the individuals that remain isolated and are less likely to have contact with the infected group, and subsequently their infection rate is much lower within the group.
Let the number of population in each group be divided into susceptible (S) and infected (I) sub-classes. Having infection from either infected sub-class, a susceptible individual becomes infected and remains in that sub-class in his/her entire life. The susceptible individuals from each group are vaccinated at a constant rate and transferred into a common vaccinated (V) sub-class. We do not consider the vertical infection and assume that susceptibles are recruited at constant rates. The flow diagram of population is shown in Figure 1 .
As mentioned earlier, we consider two different groups in the population according to their risk level. The symbols and notations are explained in Table 1 . The infection mechanism is considered to be followed by saturating incidence [2, 3, 15] defined by where α ≥ 0 determines the saturation level when the infectious population is large. When α = 0, this reduces to the mass action incidence rate. The infection rate increases with the number of infected individuals when this number is small. As the infected number increases the infection rate becomes plateaued. This phenomenon reflects the saturation of infected numbers also known as 'crowding effect'. With this assumption the dynamics of the population is governed by the following equations: 
For biological reason, we need to investigate the boundedness and positivity of the solutions of our model. To this end, the first equation can be written aṡ 
Since S r and S c are non-negative, this sub-system is cooperative. By monotone property [32] , we conclude that I r and I c are non-negative provided that I r (0) ≥ 0 & I c (0) ≥ 0. Now, we consider the boundedness of the model. By adding all the equations in (3), it can be shown that the total number of individuals satisfies
where θ = min{θ r , θ c }. Therefore, the biologically feasible region of the model (3) is 
Basic reproduction number
The model (3) has a disease-free equilibrium (
, but there is no boundary equilibria (i.e. one infected class is present while other is absent). The stability of E 0 is closely related to the notion of the basic reproduction number for the model, denoted by R 0 , which plays an important role in determining the disease persistence. The number R 0 is defined as 'the expected number of secondary cases produced, in a completely susceptible population, by a typical infected individual' (see, e.g. [7] ). This threshold parameter determines whether the disease persists or dies out from the population. We use next-generation matrix [8] to compute R 0 . The non-negative matrix F and the non-singular M -matrix V, known as new-infection and transition matrices respectively, for the system (3), are given by
It follows that
The basic reproduction number is then defined by
By Theorem 2 in [8] , we obtain the following result on the stability/instability of E 0 .
Theorem 3.1 If R 0 < 1, the DFE E 0 is locally asymptotically stable; it becomes unstable if R 0 > 1.
Global stability of E 0
In this section, we study the global stability of the DFE E 0 for the model (3). The local stability of E 0 is already established by Theorem 3.1; however, we use this theorem to further obtain the global stability of E 0 . The Jacobian matrix of Equation (3) at E 0 is given by Clearly, −(μ + θ r ) and −(μ + θ c ) are two eigenvalues of J(E 0 ) which are negative, and the other two eigenvalues are determined by the lower right block of J(E 0 ), that is,
Hence, the stability of E 0 fully depends on the matrix J 22 . For any given square matrix A, let s(A) denote the stability modulu of A (i.e. the largest real part of all eigenvalues of A). Combining the above observation and with Theorem 3.1, we immediately have following corollary.
We are now able to prove the following global result. Thus, for any ε > 0, there exists T 1 > 0 such that
Applying the estimates in Equations (5) to (4), we obtain Thus, the sub-system (4) has an upper comparison system which is linear and cooperative with following coefficient matrix:
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Obviously, A(ε) depends on ε continuously and A(0) = J 22 . Since s(J 22 ) < 0, by continuity, we can choose ε sufficiently small so that s(A(ε)) < 0. Thus, all solutions of this comparing linear system tend to (0, 0) T as → ∞. By the standard comparison argument, we conclude that for every non-negative solution of Equation (3), its I r and I c components also approach to 0 as t → ∞.
The above established limits I r (t) → 0 and I c (t) → 0 as t → ∞ indicate that the sub-system of Equation (3) consisting ofṠ r andṠ c equations has the following limit system:
Since every solution of Equation (6) tends to
T , by the theory of asymptotically autonomous systems (see,e.g. Castillo-Chaves and Thieme [6] ), the (S r (t), S c (t)) portion of any non-negative solution of Equation (3) 
T . Therefore, every non-negative solution of Equation (3) converges to the DFE E 0 . The global attractiveness of E 0 and the local stability established in Theorem 3.1 lead to the global asymptotical stability of E 0 , completing the proof of the theorem.
Persistence of the disease
When R 0 > 1, the DFE becomes unstable and it is natural to expect that the infectious populations I r and I c will remain persistent in this case. In this subsection, we confirm this expectation. Indeed, we will prove the following theorem. 
Moreover, there exists an endemic equilibrium in this case.
Proof We shall apply a theorem in [33] to prove the uniform persistence. To this end, we set 
It follows from Equations (3) and (7) that
This means that the sub-system (4) has a lower comparison system which is linear and cooperative with the coefficient matrix
Note that s(J(ξ )) is continuous in ξ and s(J(0)) > 0 (since R 0 > 1), we can choose ξ > 0 sufficiently small such that s(J(ξ )) > 0, implying that positive solutions of the lower comparing system grow exponentially. By the standard comparison argument, I r (t) or/and I c (t) components of the solution of Equation (3) grow unbounded as t → ∞. This is a contradiction to the fact that the solutions of the system (3) are ultimately bounded. Therefore, W s (E 0 ) ∩ X 0 = φ. Now, the persistence of the system (3) follows from Theorem 4.6 in [33] . Furthermore, by Theorem 3.3 in [14] , we know that uniform persistence and the dissipativity established in the previous subsection implies that system (3) has an endemic equilibrium (i.e. all components are positive). The proof of the theorem is completed.
The stability of E * will be discussed in the next subsection.
Global stability of E *
In this subsection, we investigate the global stability of the endemic equilibrium E * under the condition R 0 > 1. To this end, we apply a Lyapunov function similar to those recently used by Guo et al. [12] , Korobeinikov and Maini [17] and McCluskey [22] . Such Lyapunov functions take advantages of the properties of the function
which is positive in (0, ∞) except at x = 1, where it vanishes. For convenience of notations in constructing Lyapunov functions, we also make use of the following two functions: Obviously, V is non-negative in the positive cone and attains zero at E * . We need to show thaṫ V is negative definite. Differentiating V along the trajectories of Equation (2), we obtaiṅ 
Taking the derivative, we have
Note that h (x) only has a positive zero x 0 . It is easy to see that h(x) attains the maximum only at x 0 , which is 0. Consequently,V ≤ 0 with equality holding only at the equilibrium E * . By Hale and Lunel [13] , all positive solutions approach M, the largest invariant subset of the set {dV /dt = 0} . Since dV /dt is zero only at E * , M = {E * } is a singleton set. Thus, the equilibrium E * is globally attractive.
Discussion
In this paper, we aim to investigate the vaccine implementation policy of an infectious disease in a resource constrained environment. Transmission of a disease largely depends on the nature of infected individuals, locations, modes of transmission and infection-causing organisms. Certain group(s) of people may have high risk of receiving and transmitting infections whereas other individuals exhibit less susceptibility and infectivity. Therefore, the infection of disease significantly depends on individual's risk level. Considering this fact, we have proposed a simple two-group model incorporating vaccination rates. In our analysis, the model demonstrates a global threshold dynamics in terms of the combined parameter R 0 -the secondary infection rate referred to as the basic reproduction number, as described in Theorems 3.1, 3.3-3.5. More precisely, if R 0 < 1, then the disease will be eliminated over time; and R 0 > 1 the disease will remain endemic and infectious populations will approach to positive constant levels. Obviously, from the viewpoint of controlling the disease, one would naturally like to reduce the basic reproduction number. Thus, it is worthwhile to investigate how we can reduce R While this study offers some guidelines on vaccine implementations, our model has some limitations. We do not consider the behaviour change or the movement between the two groups. For simplicity, the model does not distinguish the infected population according to their disease progression (certain disease like HIV progress over the time) and uses a single transmission rate from all infected individuals. In our model (3), we do not distinguish the mode of transmission and population are not divided into sexes. In the case of sexually transmitted disease (STD), an individual can be infected through sexual contact or by sharing needles; other diseases, like flu or dengue, can be spread through airborne or vector-borne transmissions. We also ignore vertical transmission (mother to new born) and passive immunity to keep the model simple.
Finally, our goal is to find out an optimal vaccination strategy, not to demonstrate a rigorous analysis of a mathematical model. The formulation of the model (3) may underestimate or overestimate the real R 0 . However, this estimate does not influence the consequences of the outcome of our analysis. That is, the proper estimation of R 0 does not violate the grouping idea; rather it helps group management. The model can be improved by incorporating several realistic aspects. For example, to assert on immunization we may further incorporate the delay and waning of vaccine immunity, imperfect vaccine efficacy and impact of vaccine complicacy. We leave these as possible future research projects.
